FDA proposal to allow drug reps to circulate data draws protests

Reuters: Consumer watchdog Public Citizen has called on U.S. health regulators to withdraw a proposal that would allow pharmaceutical companies to distribute medical literature suggesting a drug's risk is less than stated on the label.

Read article